Search
for
Sort by
Research 181–210 of 1000+
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Ejaculatory dysfunction in the treatment of lower urinary tract symptoms
- 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
- The placebo effect and randomized trials: analysis of conventional medicine
- History as a Tool in Identifying “New” Old Drugs
- Dutasteride for the treatment of benign prostatic hyperplasia
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride
- Dihydrotestosteron und die Rolle der 5α-Reduktasehemmer bei der benignen Prostatahyperplasie
- Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride
- Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study
- Finasteride: The First 5α-Reductase Inhibitor
- Benign Prostatic Hyperplasia: A Disorder of Androgen Metabolism in the Male
- A population‐based nested case–control study: the use of 5‐alpha‐reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Endocrinology of the Aging Prostate: Current Concepts
- Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review
- The pathophysiology of delayed ejaculation
- Alopecia in Epidermolysis Bullosa
- Meta-Analysis of Randomized Clinical Trials of Finasteride
- Comparative Study of Therapeutic Effect of Dibenyline, Finasteride, and Combination Drugs for Symptomatic Benign Prostatic Hyperplasia
- 5α‐Reductase inhibitors and prostatic disease
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Corn silk extract improves benign prostatic hyperplasia in experimental rat model
- Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
- Comparison of clinical trials with finasteride and dutasteride.